Omalizumab, a human immunoglobulin (Ig)G1 antibody against IgE, is a therapeutic agent for bronchial asthma.The Global Initiative for Asthma guidelines indicate that the use of omalizumab should be considered as an option in step 5 of treatment for patients with the most severe type of bronchial asthma.In patients with atopic asthma who are at Happ
IntroductionPhysical activity levels of children with disabilities are low, as these children and their parents face a wide variety of both personal and environmental barriers.Behavior change techniques support pediatric physical therapists to address these barriers together with parents and children.We developed the What Moves You?! intervention T
This article proves that social protection is an effective tool for reducing poverty, contributing to the integration of economic and social aspects of sustainable development.The main purpose of this study is to evaluate the current state of the social protection system in the Republic of Kazakhstan and to develop measures to improve the level of